Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis

This study aimed to evaluate the effectiveness of fluconazole and echinocandins in the treatment of candidemia caused by both fluconazole- and echinocandin-susceptible common <i>Candida</i> species. A retrospective study which enrolled adult candidemia patients ≥19 years diagnosed at a t...

Full description

Bibliographic Details
Main Authors: Jong Hun Kim, Jin Woong Suh, Min Ja Kim
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/9/5/539
_version_ 1797599488687210496
author Jong Hun Kim
Jin Woong Suh
Min Ja Kim
author_facet Jong Hun Kim
Jin Woong Suh
Min Ja Kim
author_sort Jong Hun Kim
collection DOAJ
description This study aimed to evaluate the effectiveness of fluconazole and echinocandins in the treatment of candidemia caused by both fluconazole- and echinocandin-susceptible common <i>Candida</i> species. A retrospective study which enrolled adult candidemia patients ≥19 years diagnosed at a tertiary care hospital in the Republic of Korea from 2013 to 2018 was conducted. Common <i>Candida</i> species were defined as <i>C. albicans</i>, <i>C. tropicalis</i>, and <i>C. parapsilosis</i>. Cases of candidemia were excluded based on the following exclusion criteria: (1) candidemia showed resistance to either fluconazole or echinocandins, or (2) candidemia was caused by other <i>Candida</i> species than common <i>Candida</i> species. In order to compare the mortality rates between patients who receive fluconazole or echinocandins, the propensity scores on variables of baseline characteristics using the multivariate logistic regression analysis were employed to balance the antifungal treatment groups, and a Kaplan–Meier survival analysis was performed. Fluconazole and echinocandins were used in 40 patients and in 87 patients, respectively. The propensity score matching included 40 patients in each treatment group. After matching, the rates of 60-day mortality after candidemia were 30% in the fluconazole group and 42.5% in the echinocandins group, and a Kaplan–Meier survival analysis showed no significant difference between antifungal treatment groups, <i>p</i> = 0.187. A multivariable analysis demonstrated that septic shock was significantly associated with the 60-day mortality, whereas fluconazole antifungal treatment was not associated with an excess 60-day mortality. In conclusion, our study results suggest that fluconazole use in the treatment of candidemia caused by susceptible common <i>Candida</i> species may be not associated with increased 60-day mortality compared to echinocandins.
first_indexed 2024-03-11T03:35:08Z
format Article
id doaj.art-16c6adb28e484170b59f3c30d56fc6cb
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-11T03:35:08Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-16c6adb28e484170b59f3c30d56fc6cb2023-11-18T02:01:59ZengMDPI AGJournal of Fungi2309-608X2023-05-019553910.3390/jof9050539Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching AnalysisJong Hun Kim0Jin Woong Suh1Min Ja Kim2Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of KoreaThis study aimed to evaluate the effectiveness of fluconazole and echinocandins in the treatment of candidemia caused by both fluconazole- and echinocandin-susceptible common <i>Candida</i> species. A retrospective study which enrolled adult candidemia patients ≥19 years diagnosed at a tertiary care hospital in the Republic of Korea from 2013 to 2018 was conducted. Common <i>Candida</i> species were defined as <i>C. albicans</i>, <i>C. tropicalis</i>, and <i>C. parapsilosis</i>. Cases of candidemia were excluded based on the following exclusion criteria: (1) candidemia showed resistance to either fluconazole or echinocandins, or (2) candidemia was caused by other <i>Candida</i> species than common <i>Candida</i> species. In order to compare the mortality rates between patients who receive fluconazole or echinocandins, the propensity scores on variables of baseline characteristics using the multivariate logistic regression analysis were employed to balance the antifungal treatment groups, and a Kaplan–Meier survival analysis was performed. Fluconazole and echinocandins were used in 40 patients and in 87 patients, respectively. The propensity score matching included 40 patients in each treatment group. After matching, the rates of 60-day mortality after candidemia were 30% in the fluconazole group and 42.5% in the echinocandins group, and a Kaplan–Meier survival analysis showed no significant difference between antifungal treatment groups, <i>p</i> = 0.187. A multivariable analysis demonstrated that septic shock was significantly associated with the 60-day mortality, whereas fluconazole antifungal treatment was not associated with an excess 60-day mortality. In conclusion, our study results suggest that fluconazole use in the treatment of candidemia caused by susceptible common <i>Candida</i> species may be not associated with increased 60-day mortality compared to echinocandins.https://www.mdpi.com/2309-608X/9/5/539candidemiafluconazoleechinocandinmortality
spellingShingle Jong Hun Kim
Jin Woong Suh
Min Ja Kim
Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
Journal of Fungi
candidemia
fluconazole
echinocandin
mortality
title Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
title_full Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
title_fullStr Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
title_full_unstemmed Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
title_short Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
title_sort evaluation of fluconazole versus echinocandins for treatment of candidemia caused by susceptible common i candida i species a propensity score matching analysis
topic candidemia
fluconazole
echinocandin
mortality
url https://www.mdpi.com/2309-608X/9/5/539
work_keys_str_mv AT jonghunkim evaluationoffluconazoleversusechinocandinsfortreatmentofcandidemiacausedbysusceptiblecommonicandidaispeciesapropensityscorematchinganalysis
AT jinwoongsuh evaluationoffluconazoleversusechinocandinsfortreatmentofcandidemiacausedbysusceptiblecommonicandidaispeciesapropensityscorematchinganalysis
AT minjakim evaluationoffluconazoleversusechinocandinsfortreatmentofcandidemiacausedbysusceptiblecommonicandidaispeciesapropensityscorematchinganalysis